Skip to main content

Table 1 Cases describing the association of tetanus vaccination and GBS.

From: Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report

Case

Tetanus containing vaccine

Onset of symptoms after vaccination

Clinical presentation

Treatment

Outcome

[3]

Tetanus toxoid (1962,1971,1976)

First episode: three weeks

First episode: Progressive limb weakness. CSF was normal except a protein level of 300 mg/dL.

Symptomatic treatment and physical therapy.

First episode: Complete recovery after two months.

  

Second episode: two weeks

Second episode: Tingling and numbness, mild weakness, loss of position sense, absent DTR. CSF was normal except a protein level of 250 mg/dL.

 

Second episode: Recovery after eight months with slight hand tremors.

  

Third episode: 10 days

Third episode: Tingling and numbness, unable to walk, loss of position sense and diminished pin prick sensation below knees.

 

Third episode: Patient had only mild hand weakness by day 12.

[4]

Tetanus toxoid.

Nine days

Tingling and numbness, profound weakness of the extremities, bilateral peripheral facial paresis, bulbar weakness, bilateral weakness of ocular abduction. DTR were absent. Touch and pin prick sensation were diminished distally in lower extremities. Vital capacity was 1.6 L. CSF protein level was 550 mg/dL, no pleocytosis.

Symptomatic treatment and physical therapy

Discharge after 57 days with mild left leg weakness.

[5]

Tetanus toxoid.

Four days

Tingling of finger tips and toes, moderate weakness of four extremities. DTR were absent at ankles, knees and triceps. There was bilateral facial weakness and dysphagia. Position and vibration sense was diminished distally in four extremities. CSF protein level was 70 mg/dL.

Intravenous immunoglobulin and physical therapy

Significant improvement at six weeks. Residual facial weakness and painful twitching in both arms.

  1. CSF: cerebrospinal fluid; DTR: deep tendon reflexes